Mirae Asset Global Investments Co., Ltd. Abb Vie Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$54.3 Billion
Q1 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 722,755 shares of ABBV stock, worth $120 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

722,755

Previous 599,909 20.48%

Holding current value

$120 Million

Previous $93 Million 41.57%

% of portfolio

0.24%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $19.6 Million - $22.4 Million	122,846 Added 20.48%	722,755 $132 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $6.92 Million - $7.8 Million	50,316 Added 9.16%	599,909 $93 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $3.59 Million - $4.15 Million	26,853 Added 5.14%	549,593 $81.9 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $3.61 Million - $4.49 Million	27,211 Added 5.49%	522,740 $70.4 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $2 Million - $2.3 Million	13,797 Added 2.86%	495,529 $79 Million

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $4.43 Million - $5.31 Million	32,008 Added 7.12%	481,732 $77.9 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $1.95 Million - $2.24 Million	14,541 Added 3.34%	449,724 $60.4 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $14 Million - $17.8 Million	101,821 Added 30.54%	435,183 $66.7 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $1.54 Million - $1.96 Million	-11,186 Reduced 3.25%	333,362 $51.1 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $190,183 - $235,963	1,441 Added 0.42%	344,548 $55.9 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $1.48 Million - $1.87 Million	13,735 Added 4.17%	343,107 $46.5 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2.78 Million - $3.16 Million	26,174 Added 8.63%	329,372 $35.5 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $2.56 Million - $2.85 Million	24,306 Added 8.72%	303,198 $34.2 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $4.4 Million - $4.85 Million	43,021 Added 18.24%	278,892 $30.2 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $2.03 Million - $2.75 Million	25,275 Added 12.0%	235,871 $25.3 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $2.2 Million - $2.58 Million	-25,579 Reduced 10.83%	210,596 $18.4 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $4.49 Million - $6.01 Million	61,254 Added 35.02%	236,175 $23.2 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $1.55 Million - $2.35 Million	-24,056 Reduced 12.09%	174,921 $13.3 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $7.33 Million - $9.17 Million	101,580 Added 104.29%	198,977 $17.6 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $489,543 - $588,571	-7,773 Reduced 7.39%	97,397 $7.38 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $168,586 - $215,492	-2,566 Reduced 2.38%	105,170 $7.62 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $228,951 - $269,464	-2,968 Reduced 2.68%	107,736 $8.68 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $373,835 - $461,040	-4,802 Reduced 4.16%	110,704 $10.2 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $2.85 Million - $3.17 Million	32,046 Added 38.4%	115,506 $10.9 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.02 Million - $1.2 Million	11,312 Added 15.68%	83,460 $7.73 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $3.55 Million - $4.75 Million	-38,535 Reduced 34.82%	72,148 $6.83 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $1.13 Million - $1.24 Million	12,627 Added 12.88%	110,683 $10.7 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $1.71 Million - $2.18 Million	24,412 Added 33.15%	98,056 $8.71 Million
Q2 2017 Aug 14, 2017	BUY	N/A	73,644	73,644 $5.34 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Abb Vie Inc. Transaction History